Cormorant Asset Management’s Immunovant, Inc. Units IMVTU Stock Holding History

Cormorant Asset Management’s Portfolio IMVTU Stock Details IMVTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,078,380	Closed	-$19.4M	–	87
2020 Q1	$19.4M	Sell	1,078,380 -1,620	-0.2%	-$31.3K	0.9%	36
2019 Q4	$26.5M	Buy	+1,080,000	New	+$23.3M	1.06%	37

Cormorant Asset Management's IMVTU Position: Q2 2020 in Review

Cormorant Asset Management sold out of Immunovant, Inc. Units (IMVTU) in Q2 2020, closing a stake of 1,078,380 shares — an estimated $19.4M sold.

Cormorant Asset Management first reported a position in IMVTU in Q4 2019 and held it in 2 quarters. The position peaked at $26.5M in Q4 2019. 0 funds tracked by Wall St. Rank hold IMVTU as of Q2 2020.

Cormorant Asset Management reported no remaining Immunovant, Inc. Units position as of Q2 2020 after selling out during the quarter.
Cormorant Asset Management sold 1,078,380 Immunovant, Inc. Units shares in Q2 2020, an estimated $19.4M.
Cormorant Asset Management first reported a position in Immunovant, Inc. Units in Q4 2019 and held it in 2 quarters.
Cormorant Asset Management's Immunovant, Inc. Units position peaked at $26.5M in Q4 2019.
0 funds tracked by Wall St. Rank held Immunovant, Inc. Units as of Q2 2020.

Based on Cormorant Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.